Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Moriah Plath of 'Welcome to Plathville' shares her emotional journey with alopecia after losing her hair, eyebrows and ...

Landon Jackson was diagnosed with alopecia at five years old. Even as he begins his rookie season in the NFL, he still ...

Alopecia areata patients also often have other autoimmune disorders. About three in 10 people with alopecia areata have autoimmune thyroid disease, and the same ratio stands with rates of eczema ...

Alopecia areata patients also often have other autoimmune disorders. About three in 10 people with alopecia areata have autoimmune thyroid disease, and the same ratio stands with rates of eczema ...

HealthDay News — For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the American Academy of ...

TUESDAY, March 18, 2025 (HealthDay News) -- For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily, oral ...

Key takeaways: 42.4% of adolescents with severe alopecia areata who received baricitinib had 80% or more scalp hair coverage after 36 weeks. An expert said it is the largest trial to date studying ...

1 Passeron T, et al. Baricitinib provides significant hair regrowth in adolescents with severe alopecia areata: 36-week efficacy and safety results from a Phase 3 randomized, controlled trial.